objective is to determine the frequency of medical management of urinary symptoms after transurethral resection of the prostate (TURP).
INTRODUCTION AND OBJECTIVES:
The prevalence of benign prostatic hyperplasia (BPH) and its associated disability ranging from quality of life impairments to hospitalization, has spurred decades of research into its pathophysiology, diagnosis, treatment, and outcomes. For these reasons, we conducted a study to characterize the current landscape of BPH literature, including the most commonly cited articles impacting the field.
METHODS: We used the Web of ScienceTM database to conduct a bibliometric analysis of the top 100 leading BPH articles. Bibliometric analyses are quantitative approaches examining the impact of academic literature. We used the following search terms: 'benign prostatic hyperplasia' and 'benign prostatic enlargement.' We identified and characterized the 100 most-cited BPH articles including their citations, journal, author, year, and country through September 2018.
RESULTS: The top 100 articles were published between 1978 and 2012. Citation number ranged from 143 to 2,158 across 26 different journals, including 9 urology-specific journals. The Journal of Urology (5-year impact factor: 4.91) was the most published journal with 26 articles, followed by European Urology (5-year impact factor: 15.66) with 16, and Urology (5-year impact factor: 2.39) with 13. The oldest 10 articles in the top 100 mainly focused on BPH etiology/ pathogenesis, while the newest 10 articles mainly focused on medical treatment. The 1990's was the most productive decade accounting for nearly half of the top 100 articles (n[46). Eight authors had two or more first author publications, and 8 institutions had five or more publications in the top 100. Thirteen different countries were represented, with the US (n[64), Italy (n[7), and Germany (n[5) being the most common. The articles were in the following Web of Science Categories: Urology & Nephrology (n[68), Medicine, General & Internal (n[15), and Endocrinology & Metabolism (n[7) .
CONCLUSIONS: This represents the first bibliometric analysis of the leading 100 BPH articles impacting the academic literature. The literature focus has evolved from BPH pathogenesis/etiology to treatment, and was primarily published in 3 specialty journals. Our findings highlight the most impactful BPH literature, and may be used to guide research and funding priorities for this increasingly common condition.
Source of Funding: none

PD19-08 MARIJUANA, ALCOHOL, ED AND DEPRESSION: EPIDEMIOLOGIC CORRELATIONS WITH BPH/LUTS
Heather Carmichael, Aurora, CO; Granville Lloyd*, Denver, CO INTRODUCTION AND OBJECTIVES: Benign prostatic hyperplasia with lower urinary tract symptoms (BPH/LUTS) is a disease with high prevalence, societal impact and cost. Our aim was to explore associations including marijuana usage, alcohol usage and other medical comorbidities with BPH/LUTS treatment.
METHODS: We queried our hospital network database of nearly two million patients for data from the electronic medical record between January 2011 and October 2018. Men over the age of 40 who were on medical therapy for LUTS (selective alpha blockade and/or finasteride) were included. Patients with only one recorded visit or with a diagnosis of bladder/prostate malignancy were excluded. Medical therapy for LUTS was defined based on prescriptions for tamsulosin, alfuzosin and/or finasteride 5mg. Alcohol (AL) and marijuana (MJ) use were found from diagnosis code and/or social history text. Medical comorbidities including depression, obesity or metabolic syndrome (MetS), hypertension (HTN), erectile dysfunction (ED), hypogonadism, and diabetes (DM) were identified based on ICD-9/10 codes. Multivariable logistic regression was used to control for multiple additional confounders including patient age, race, insurance type, BMI, and vital signs.
Alcohol (AL) and marijuana (MJ) use were found from diagnosis code and/or social history text. Medical diagnoses were based on ICD-9/10 codes. Multiple logistic regression was used to control for multiple confounders including patient age, race, insurance type, comorbidities, BMI, and vital signs. RESULTS: 173,469 patients were included; 20,548 (11.9%) were on medical treatment for LUTS. On univariable analysis, MJ use and ED were associated with increased risk of being on a LUTS medication. AL use was associated with decreased risk of being on a LUTS medication.
On multivariable analysis, MJ remained associated with an increased risk of LUTS medication, as did ED and depression. AL use had no significant association with LUTS treatment. (TABLE) CONCLUSIONS: Men with depression, marijuana usage, HTN, MetS, ED, hypogonadism and DM were more likely to be treated for LUTS, but alcohol use use was not associated. Marijuana use is a newly described association with LUTS and understanding of this interplay is desirable.
